Evidence map›Paper›PMID 32420686›Full record

ArticleMolecular genetics & genomic medicine2020

A novel dominant mutation in CRYAB gene leading to a severe phenotype with childhood onset.

Ana T Marcos, Diego Amorós, Beatriz Muñoz-Cabello, Francisco Galán, Eloy Rivas Infante, Luis Alcaraz-Mas, José M Navarro-Pando

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Panorama of the distal myopathies.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ana T MarcosUnidad de Genética, INEBIR (Instituto para el estudio de la Biología de la Reproducción Humana), Seville, Spain.ORCID 0000-0002-0263-7473
Diego AmorósBioArray, Universidad Miguel Hernández de Elche, Elche, Alicante, Spain.ORCID 0000-0003-2035-6189
Beatriz Muñoz-CabelloSección de Neuropediatría, Hospital Virgen del Rocío, Sevilla, Spain.ORCID 0000-0002-7211-8804
Francisco GalánBioArray, Universidad Miguel Hernández de Elche, Elche, Alicante, Spain.ORCID 0000-0001-6763-0523
Eloy Rivas InfanteUnidad de Neuropatología, Hospital Virgen del Rocío, Sevilla, Spain.ORCID 0000-0001-6014-8048
Luis Alcaraz-MasBioArray, Universidad Miguel Hernández de Elche, Elche, Alicante, Spain.ORCID 0000-0002-2485-0726
José M Navarro-PandoUnidad de Genética, INEBIR (Instituto para el estudio de la Biología de la Reproducción Humana), Seville, Spain.ORCID 0000-0003-2362-2251
Universitat de Miguel Hernández d'Elx · ESHospital Universitario Virgen del Rocío · ESUniversidad Europea del Atlántico · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundαB-crystallin is a promiscuous protein involved in numerous cell functions. Mutations in CRYAB have been found in patients with different pathological phenotypes that are not properly understood. Patients can present different diseases like cataracts, muscle weakness, myopathy, cardiomyopathy, respiratory insufficiency or dysphagia, but also a variable combination of these pathologies has been found. These mutations can show either autosomal dominant or recessive mode of inheritance and variable penetrance and expressivity. This is the first report of congenital cataracts and myopathy described in childhood due to a CRYAB mutation with autosomal dominant mode of inheritance.

methodsThe whole exome sequence was subjected to phenotype-driven analysis and a novel variant in CRYAB was detected: c.514delG, p.(Ala172ProfsTer14). The mutation was located in the C-terminal domain of the protein, which is essential for chaperone activity. The deduced protein was analyzed searching for alterations of the relevant physico-chemical properties described for this domain. A muscle biopsy was also tested for CRYAB with immunohistochemical and histoenzymatic techniques.

resultsCRYAB displayed a mild immunoreactivity in the subsarcolemmal compartment with no pathological sarcoplasmic accumulation. It agrees with an alteration of the physico-chemical properties predicted for the C-terminal domain: hydrophobicity, stiffness, and isomerization.

conclusionsThe described mutation leads to elongation of the protein at the carboxi-terminal domain (CTD) with altered properties, which are essential for solubility and activity. It suggests that can be the cause of the severe conditions observed in this patient.

Indexed as

Phenotypealpha-Crystallin B ChainCataractChild, PreschoolGenes, DominantHumansMaleMuscle, SkeletalMutationMyotonia CongenitaSyndromeTwinsalpha-Crystallin B ChainCRYAB protein, humancardiomyopathycataractsCRYABcrystallinopathyHspB5myopathyαB-crystallin

Identifiers

PMID32420686
PMCPMC7434720
OpenAlexW3025089015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.